- The Wall Street Journal•2 hours ago
Companies don’t usually root for their competitors, but Biogen is pulling for Eli Lilly. The latter’s pending data for its experimental Alzheimer’s disease treatment will be an important read-through for ...
- Business Wire•8 hours agoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Biogen Inc. and Encourages Investors with Losses to Contact the Firm
Lundin Law PC, a shareholder rights firm, announces a class action lawsuit has been filed against Biogen Inc. concerning possible violations of federal securities laws between July 23, 2014 and July 23, 2015 inclusive .
Biogen Inc. (BIIB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Day's Range||291.30 - 301.34|
|52wk Range||223.02 - 333.65|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||17.32|
|Avg Vol (3m)||1,569,140|
|Dividend & Yield||N/A (N/A)|